INNOVATE Corp. (VATE)
NYSE: VATE · Real-Time Price · USD
4.220
-0.170 (-3.87%)
At close: Nov 17, 2026, 4:00 PM EST
4.300
+0.080 (1.90%)
After-hours: Nov 17, 2026, 7:20 PM EST

INNOVATE Earnings Call Transcripts

Fiscal Year 2026

  • Q3 revenue rose 42.8% YoY to $495.5 million and adjusted EBITDA more than doubled to $40.5 million, driven by infrastructure. DBM Global and broadcasting sales reshaped the portfolio and enabled substantial debt reduction, while MediBeacon and R2 advanced commercialization.

  • Q2 2026 revenue surged 74.2% year-over-year to $421.6 million, driven by record Infrastructure results and margin expansion. Net income reached $10.4 million, reversing a prior loss, while strategic refinancing and a pending Broadcasting sale strengthened the balance sheet.

  • AGM 2026

    Directors and executive officers were introduced, and all four shareholder proposals—including director elections, executive compensation, equity plan amendment, and auditor ratification—were approved. No questions were submitted during the Q&A session.

  • Q1 2026 saw 33% revenue growth to $364.8M and improved adjusted EBITDA, driven by infrastructure gains, while Life Sciences and Spectrum faced revenue declines. Net loss narrowed, cash increased, and backlog remains strong, supporting a positive outlook.

Fiscal Year 2025

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022